Please use this identifier to cite or link to this item: https://dora.health.qld.gov.au/qldresearchjspui/handle/1/11910
Title: Hamate autograft for proximal pole scaphoid fracture: A systematic review
Authors: Dragan, Z.;George, A. R.;Graham, D. J.;Sivakumar, B. S.
Issue Date: 2025
Source: Hand Surg Rehabil, 2025 (44) 3 p.102129
Pages: 102129
Journal Title: Hand Surg Rehabil
Abstract: BACKGROUND: Proximal pole scaphoid fracture is not uncommon and present therapeutic challenges due to impaired perfusion, with risk of secondary non-union, avascular necrosis and wrist degeneration. There is no consensus on surgical techniques for a non-salvageable proximal pole, but proximal hamate autograft to resurface the scaphoid is gaining interest. This systematic review assesses the evidence for proximal hamate autograft in resurfacing non-salvageable scaphoid proximal poles. METHODS: A systematic review searched the Medline, Embase, PubMed and Scopus databases for the period 2000-2024, following PRISMA guidelines. The protocol was registered with PROSPERO. Risk of bias was measured using ROBINS-I (Risk Of Bias In Non-randomized Studies - of Interventions). RESULTS: Mean duration of non-union at presentation was 50.8 months (n = 10), with a mean follow-up of 15.7 months (n = 10). Mean hamate graft length was 6.7 mm (n = 26). Radiographic union was achieved in 93.3% of patients (n = 30), at a mean 10.6 weeks (n = 26). Mean postoperative wrist flexion-extension was 89.5° (n = 10), averaging 61.4% of the arc for the contralateral hand (n = 8). Pronation and supination recovered contralateral values (n = 5). Postoperative grip strength in the affected hand was 79.8% of the contralateral value (n = 26). Postoperative QuickDASH score and VAS pain rating averaged 25 (n = 8) and 2 (n = 21), respectively. Five patients (16.7%; n = 30) experienced complications. CONCLUSIONS: Hamate autografting for resurfacing non-salvageable scaphoid proximal poles demonstrated satisfactory early-to-medium-term outcomes. Although promising, more research is necessary to confirm the utility of this treatment modality. LEVEL OF EVIDENCE: IV (systematic review).
DOI: 10.1016/j.hansur.2025.102129
Appears in Sites:Children's Health Queensland Publications
Queensland Health Publications

Show full item record

Page view(s)

14
checked on Oct 6, 2026

Google ScholarTM

Check

Altmetric


Items in DORA are protected by copyright, with all rights reserved, unless otherwise indicated.